No Data
No Data
UBS Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Maintains Target Price $285
Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change
Fed Dot Plot in Full View as Market Holds on a Higher Note: Live Stock News
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Green Gives Way to Red on Gossamer Macro Expectations: Live Stock News
West Pharma Initiated at Outperform by Evercore ISI Group